Clinical and Experimental Reproductive Medicine

  • 제49권3호
  • /
  • Pages.168-174
  • /
  • 2022
  • /
  • 2233-8233(pISSN)
  • /
  • 2233-8241(eISSN)
대한생식의학회 (The Korean Society for Reproductive Medicine)
권호 표지
DOI QR코드

DOI QR Code

Platelet-rich plasma treatment in patients with refractory thin endometrium and recurrent implantation failure: A comprehensive review

  • 투고 : 2022.04.11
  • 심사 : 2022.08.10
  • 발행 : 2022.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Refractory thin endometrium and recurrent implantation failure are among the most challenging infertility-related factors hindering successful pregnancy. Several adjuvant therapies have been investigated to increase endometrial thickness and the pregnancy rate, but the treatment effect is still minimal, and for many patients, these treatment methods can be quite costly and difficult to approach. Platelet-rich plasma (PRP) is an autologous concentration of platelets in plasma and has recently been elucidated as a better treatment option for these patients. PRP is rich in cytokines and growth factors, which are suggested to exert a regenerative effect at the level of the injured tissue. Another advantage of PRP is that it is easily obtained from the patient's own blood. We aimed to review the recent findings of PRP therapy used for patients with refractory thin endometrium and recurrent implantation failure.

키워드

참고문헌

  1. Dessolle L, Darai E, Cornet D, Rouzier R, Coutant C, Mandelbaum J, et al. Determinants of pregnancy rate in the donor oocyte model: a multivariate analysis of 450 frozen-thawed embryo transfers. Hum Reprod 2009;24:3082-9. https://doi.org/10.1093/humrep/dep303
  2. Davar R, Janati S, Mohseni F, Khabazkhoob M, Asgari S. A comparison of the effects of transdermal estradiol and estradiol valerate on endometrial receptivity in frozen-thawed embryo transfer cycles: a randomized clinical trial. J Reprod Infertil 2016;17:97-103.
  3. Weckstein LN, Jacobson A, Galen D, Hampton K, Hammel J. Lowdose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Fertil Steril 1997;68:927-30. https://doi.org/10.1016/S0015-0282(97)00330-0
  4. Sher G, Fisch JD. Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertil Steril 2002;78:1073-6. https://doi.org/10.1016/S0015-0282(02)03375-7
  5. Kunicki M, Lukaszuk K, Liss J, Skowronska P, Szczyptanska J. Granulocyte colony stimulating factor treatment of resistant thin endometrium in women with frozen-thawed blastocyst transfer. Syst Biol Reprod Med 2017;63:49-57. https://doi.org/10.1080/19396368.2016.1251505
  6. Mints M, Jansson M, Sadeghi B, Westgren M, Uzunel M, Hassan M, et al. Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient. Hum Reprod 2008;23:139-43.
  7. Taylor HS. Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA 2004;292:81-5. https://doi.org/10.1001/jama.292.1.81
  8. Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, et al. Recurrent implantation failure: definition and management. Reprod Biomed Online 2014;28:14-38. https://doi.org/10.1016/j.rbmo.2013.08.011
  9. Magdi Y, El-Damen A, Fathi AM, Abdelaziz AM, Abd-Elfatah Youssef M, Abd-Allah AA, et al. Revisiting the management of recurrent implantation failure through freeze-all policy. Fertil Steril 2017;108:72-7. https://doi.org/10.1016/j.fertnstert.2017.04.020
  10. Mouanness M, Ali-Bynom S, Jackman J, Seckin S, Merhi Z. Use of intra-uterine injection of platelet-rich plasma (PRP) for endometrial receptivity and thickness: a literature review of the mechanisms of action. Reprod Sci 2021;28:1659-70. https://doi.org/10.1007/s43032-021-00579-2
  11. Amable PR, Carias RB, Teixeira MV, da Cruz Pacheco I, Correa do Amaral RJ, Granjeiro JM, et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell ResTher 2013;4:67.
  12. Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author's perspective. J Cutan Aesthet Surg 2014;7:189-97. https://doi.org/10.4103/0974-2077.150734
  13. Arora S, Agnihotri N. Platelet derived biomaterials for therapeutic use: review of technical aspects. Indian J Hematol Blood Transfus 2017;33:159-67. https://doi.org/10.1007/s12288-016-0669-8
  14. Oudelaar BW, Peerbooms JC, Huis In 't Veld R, Vochteloo AJ. Concentrations of blood components in commercial platelet-rich plasma separation systems: a review of the literature. Am J Sports Med 2019;47:479-87. https://doi.org/10.1177/0363546517746112
  15. Lee KS. Ultrasound-guided platelet-rich plasma treatment: application and technique. Semin Musculoskelet Radiol 2016;20:422-31. https://doi.org/10.1055/s-0036-1594287
  16. Marx R. Platelet-function: assays and events: introduction. Suppl Thromb Haemost 1978;63:65-80.
  17. Alves R, Grimalt R. A review of platelet-rich plasma: history, biology, mechanism of action, and classification. Skin Appendage Disord 2018;4:18-24. https://doi.org/10.1159/000477353
  18. Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009;23:177-89. https://doi.org/10.1016/j.blre.2009.04.001
  19. Matsumoto H, Nasu K, Nishida M, Ito H, Bing S, Miyakawa I. Regulation of proliferation, motility, and contractility of human endometrial stromal cells by platelet-derived growth factor. J Clin Endocrinol Metab 2005;90:3560-7. https://doi.org/10.1210/jc.2004-1918
  20. Bauer SM, Bauer RJ, Velazquez OC. Angiogenesis, vasculogenesis, and induction of healing in chronic wounds. Vasc Endovascular Surg 2005;39:293-306. https://doi.org/10.1177/153857440503900401
  21. Stoikos CJ, Harrison CA, Salamonsen LA, Dimitriadis E. A distinct cohort of the TGFbeta superfamily members expressed in human endometrium regulate decidualization. Hum Reprod 2008;23:1447-56. https://doi.org/10.1093/humrep/den110
  22. Demir R, Yaba A, Huppertz B. Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantation. Acta Histochem 2010;112:203-14. https://doi.org/10.1016/j.acthis.2009.04.004
  23. Carlson MJ, Thiel KW, Yang S, Leslie KK. Catch it before it kills: progesterone, obesity, and the prevention of endometrial cancer. Discov Med 2012;14:215-22.
  24. Walsh TG, Metharom P, Berndt MC. The functional role of platelets in the regulation of angiogenesis. Platelets 2015;26:199-211. https://doi.org/10.3109/09537104.2014.909022
  25. Marini MG, Perrini C, Esposti P, Corradetti B, Bizzaro D, Riccaboni P, et al. Effects of platelet-rich plasma in a model of bovine endometrial inflammation in vitro. Reprod Biol Endocrinol 2016;14:58. https://doi.org/10.1186/s12958-016-0195-4
  26. Giusti I, Rughetti A, D'Ascenzo S, Millimaggi D, Pavan A, Dell'Orso L, et al. Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells. Transfusion 2009;49:771-8. https://doi.org/10.1111/j.1537-2995.2008.02033.x
  27. Molina A, Sanchez J, Sanchez W, Vielma V. Platelet-rich plasma as an adjuvant in the endometrial preparation of patients with refractory endometrium. JBRA Assist Reprod 2018;22:42-8.
  28. Chang Y, Li J, Wei LN, Pang J, Chen J, Liang X. Autologous platelet-rich plasma infusion improves clinical pregnancy rate in frozen embryo transfer cycles for women with thin endometrium. Medicine (Baltimore) 2019;98:e14062. https://doi.org/10.1097/MD.0000000000014062
  29. Kim H, Shin JE, Koo HS, Kwon H, Choi DH, Kim JH. Effect of autologous platelet-rich plasma treatment on refractory thin endometrium during the frozen embryo transfer cycle: a pilot study. Front Endocrinol (Lausanne) 2019;10:61. https://doi.org/10.3389/fendo.2019.00061
  30. Kim JH, Park M, Paek JY, Lee WS, Song H, Lyu SW. Intrauterine infusion of human platelet-rich plasma improves endometrial regeneration and pregnancy outcomes in a murine model of Asherman's syndrome. Front Physiol 2020;11:105.
  31. Kim MK, Yoon JA, Yoon SY, Park M, Lee WS, Lyu SW, et al. Human platelet-rich plasma facilitates angiogenesis to restore impaired uterine environments with Asherman's syndrome for embryo implantation and following pregnancy in mice. Cells 2022;11:1549. https://doi.org/10.3390/cells11091549
  32. de Miguel-Gomez L, Lopez-Martinez S, Campo H, Frances-Herrero E, Faus A, Diaz A, et al. Comparison of different sources of platelet-rich plasma as treatment option for infertility-causing endometrial pathologies. Fertil Steril 2021;115:490-500. https://doi.org/10.1016/j.fertnstert.2020.07.053
  33. Agarwal M, Mettler L, Jain S, Meshram S, Gunther V, Alkatout I. Management of a thin endometrium by hysteroscopic instillation of platelet-rich plasma into the endomyometrial junction: a pilot study. J Clin Med 2020;9:2795. https://doi.org/10.3390/jcm9092795
  34. Dogra Y, Singh N, Vanamail P. Autologous platelet-rich plasma optimizes endometrial thickness and pregnancy outcomes in women with refractory thin endometrium of varied aetiology during fresh and frozen-thawed embryo transfer cycles. JBRA Assist Reprod 2022;26:13-21.
  35. Zamaniyan M, Peyvandi S, Heidaryan Gorji H, Moradi S, Jamal J, Yahya Poor Aghmashhadi F, et al. Effect of platelet-rich plasma on pregnancy outcomes in infertile women with recurrent implantation failure: a randomized controlled trial. Gynecol Endocrinol 2021;37:141-5. https://doi.org/10.1080/09513590.2020.1756247
  36. Nazari L, Salehpour S, Hosseini S, Sheibani S, Hosseinirad H. The effects of autologous platelet-rich plasma on pregnancy outcomes in repeated implantation failure patients undergoing frozen embryo transfer: a randomized controlled trial. Reprod Sci 2022;29:993-1000. https://doi.org/10.1007/s43032-021-00669-1
  37. Bakhsh AS, Maleki N, Sadeghi MR, SadeghiTabar A, Tavakoli M, Zafardoust S, et al. Effects of autologous platelet-rich plasma in women with repeated implantation failure undergoing assisted reproduction. JBRA Assist Reprod 2022;26:84-7.
  38. Xu Y, Hao C, Fang J, Liu X, Xue P, Miao R. Intrauterine perfusion of autologous platelet-rich plasma before frozen-thawed embryo transfer improves the clinical pregnancy rate of women with recurrent implantation failure. Front Med (Lausanne) 2022;9:850002.